Prune Belly Syndrome Characterization and Management

Prune Belly Syndrome (PBS) is a rare congenital disorder characterised by a triad of deficient or absent abdominal wall musculature, dilatation of the urinary tract with poorly contractile smooth muscle, and undescended testes predominantly in male infants. The weakened abdominal wall contributes to a distinctive wrinkled appearance and may exacerbate respiratory compromise. Urinary tract anomalies range from ureteral dilatation and mega‐bladder to renal dysplasia, with severity of renal impairment dictating long‐term prognosis. Although the genetic basis has remained elusive, recent insights point to defects in mechanosensitive and cytoskeletal proteins. Prenatal ultrasonography allows early detection, informing perinatal management. Therapeutic strategies span staged surgical interventions—abdominoplasty, ureteric re‐implantation and orchiopexy—and intensive renal and respiratory support. In cases progressing to end‐stage renal disease, renal replacement therapy and transplantation become pivotal. A coordinated, multidisciplinary approach encompassing urology, nephrology, neonatology and physiotherapy has improved survival and functional outcomes. Emerging molecular discoveries herald the potential for targeted treatments that address underlying mechanotransduction defects.

Research from Nature Portfolio

Recent studies have elucidated a mechanistic role for the ion channel PIEZO1 in the pathophysiology of Prune Belly Syndrome. Whole‐exome sequencing in affected individuals revealed compound heterozygous loss‐of‐function variants in PIEZO1, a cation‐selective channel activated by mechanical stress within the lower urinary tract. Functional assays demonstrated markedly reduced channel open probability under physiologically relevant pressure, while application of a selective small‐molecule agonist restored normal activity in vitro. These findings constitute the first direct link between impaired mechanosensation and bladder hypocontractility in PBS and suggest that pharmacological activation of PIEZO1 may represent a novel therapeutic avenue to improve urinary function.

Prune Belly Syndrome Characterization and Management publication trend

The graph below shows the total number of articles in prune belly syndrome characterization and management across all publications each year (not limited to Nature Index journals).

Technical terms

Prune Belly Syndrome: Rare congenital condition characterised by deficient abdominal musculature, urinary tract dilatation and undescended testes.

PIEZO1: Mechanosensitive cation‐selective ion channel expressed in the smooth muscle of the urinary tract.

Filamin A (FLNA): X‐linked actin‐crosslinking protein that functions as a mechanosensing scaffold in smooth muscle cells.

Renal replacement therapy: Medical procedures, including dialysis and transplantation, that substitute for impaired kidney function.

Cryptorchidism: Failure of one or both testes to descend into the scrotum.

References

1. PIEZO1 loss-of-function compound heterozygous mutations in the rare congenital human disorder Prune Belly Syndrome. Nature Communications (2024).
2. Prune belly syndrome in surviving males can be caused by Hemizygous missense mutations in the X-linked Filamin A gene. BMC Medical Genomics (2020).
3. The Prune Belly syndrome: urological aspects and long-term outcomes of a rare disease. Pediatric Reports (2012).
4. Outcomes of renal replacement therapy in boys with prune belly syndrome: findings from the ESPN/ERA-EDTA Registry. Pediatric Nephrology (2017).